Joseph W. Laplume
At a glance: Joseph W. Laplume is Evp, Corp Strategy & Develop at Charles River Laboratories (CRL). Their latest SEC Form 4, filed Mar 4, 2026, reported a purchase of $4K. On file: 1 purchase line ($4K) and 1 sale line ($65K).
Disclosed holdings: about $8.6M of CRL stock: 27,448 shares reported on their latest Form 4 (filed Mar 4, 2026), valued at the Nov 20, 2026 close of $314.32. This counts only CRL shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Evp, Corp Strategy & Develop at Charles River Laboratories International, Inc. (CRL)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Joseph W. Laplume's InsiderPrint
2 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.
- Bump outward: a purchase (1)
- Dent inward: a sale (1)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Mar 4SEC | CRLCharles River Laboratories International, Inc.First buy | Buy | 2527,448 held (+0%) | $174.54 | $4K | +80.1% |
| Jan 20SEC | CRLCharles River Laboratories International, Inc. | Sell | 40023,716 held (−2%) | $163.72 | $65K | +92.0% |
- Buy
Evp, Corp Strategy & Develop Joseph W Laplume bought $4K of CRL at $174.54 — first open-market purchase in our records.
Follow Joseph W. Laplume
Get one email when Joseph W. Laplume files a new purchase or sale. Free.
At most one email a day about Joseph W. Laplume, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.